Phytochemical Profiling and Anticancer Potential of Praecitrullus fistulosus Fruit Extracts on Ehrlich Ascites Carcinoma (EAC) Cell Lines
Keywords:
Praecitrullus fistulosus, anticancer activity, Erlich Ascites Carcinoma, bioactive compounds, phenolic content, flavonoid content, in vitro, in vivo, tumor reduction,, traditional medicine, natural products, chemotherapy, cancer therapyAbstract
The global incidence of cancer has prompted extensive research into finding novel, selective anticancer agents that target tumor cells while minimizing harm to normal cells. Traditional medicine, especially the use of plant-based compounds, has emerged as a promising source for discovering such therapeutic agents. This study investigates the potential anticancer activity of Praecitrullus fistulosus, a plant used in traditional medicine. The fruits of P. fistulosus were extracted using various solvents, including petroleum ether, chloroform, ethyl acetate, acetone, and ethanol, and were evaluated for their total phenolic and flavonoid contents. The ethanolic extract demonstrated the highest concentrations of both phenolic (24 mg/g) and flavonoid (21.28 mg/g) compounds. In vitro and in vivo assays were performed to assess the anticancer potential of these extracts. The in vivo study on Erlich Ascites Carcinoma (EAC) tumor-bearing mice showed a significant reduction in tumor volume, packed cell volume, and viable tumor cell count in treated groups, with the ethanol extract showing the most potent effect. The results suggest that the anticancer properties of P. fistulosus may be attributed to its high content of bioactive compounds, particularly polyphenolics and flavonoids, which likely exert both direct cytotoxic and antioxidant effects on tumor cells. This research highlights Praecitrullus fistulosus as a promising candidate for the development of novel anticancer therapies, warranting further investigation into its therapeutic potential.
Downloads
References
Greenwell M., Rahman P.K. Medicinal Plants: Their Use in Anticancer Treatment. Int. J. Pharm. Sci. Res.
2015;6:4103–4112. doi: 10.13040/IJPSR.0975-8232.6(10).4103-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
Siegel R.L., Miller K.D., Jemal A. Cancer Statistics, 2017. CA Cancer J. Clin. 2017;67:7–30. doi: 10.3322/caac.21387. [DOI] [PubMed] [Google Scholar]
Banerjee P., Erehman J., Gohlke B.O., Wilhelm T., Preissner R., Dunkel M. Super Natural II—A database of natural products. Nucleic Acids Res. 2015;43:D935–D939. doi: 10.1093/nar/gku886. [DOI] [PMC free article] [PubMed] [Google Scholar]
Fridlender M., Kapulnik Y., Koltai H. Plant derived substances with anti-cancer activity: From folklore to practice. Front. Plant Sci. 2015;6:1–9. doi: 10.3389/fpls.2015.00799. [DOI] [PMC free article] [PubMed] [Google Scholar]
Chekem L., Wierucki S. Extraction of artemisinin and synthesis of its derivates artesunate and artemether. Med. Trop. 2006;66:602–605. [PubMed] [Google Scholar]
Kumar A. Vincristine and Vinblastine: A Review. Int. J. Med. Pharm. 2016;6:23–30. [Google Scholar]
Denis J.N., Greene A.E., Guenard D., Gueritte-Voegelein F., Mangattal L., Potier P. A highly efficient, practical approach to natural taxol. J. Am. Chem. Soc. 1988;110:5917–5919. doi: 10.1021/ja00225a063. [DOI] [Google Scholar]
Bocca C. Taxol: A short history of a promising anticancer drug. Minerva Biotecnol. 1998;10:81. [Google Scholar]
Holton R.A., Somoza C., Kim H.B., Liang F., Biediger R.J., Boatman P.D., Shindo M., Smith C.C., Kim S., Nadizadeh H., et al. First total synthesis of taxol. 1. Functionalization of the B ring. J. Am. Chem. Soc. 1994;116:1597–1598. doi: 10.1021/ja00083a066. [DOI] [Google Scholar]
Nicolaou K.C., Yang Z., Liu J.J., Ueno H., Nantermet P.G., Guy R.K., Claiborne C.F., Renaud J., Couladouros E.A., Paulvannan K., et al. Total synthesis of taxol. Nature. 1994;367:630–634. doi: 10.1038/367630a0. [DOI] [PubMed] [Google Scholar].
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
